Literature DB >> 200715

Replication of herpes simplex virus DNA after removal of hydroxyurea block from infected cells.

J Shlomai, Y Becker.   

Abstract

Hydroxyurea (HU) treatment of HSV-infected cells markedly inhibits the synthesis of virus DNA. Only 0-3.6 of the 3H-thymidine label was incorporated into virus DNA in the presence of HU as compared to untreated infected cells. Removal of HU resulted in a renewed synthesis of virus DNA as determined by the gradual increase in the incorporation of 3H-thymidine into HSV DNA. The labelled virus DNA molecules were isolated and chromatographed on benzoylated napthoylated DEAE (BND)-cellulose columns to separate the replicative intermediates that have single-stranded (ss) sequences from the mature double-stranded (ds) DNA genomes. Mature radioactive dsDNA molecules were found to appear at 22 min after removal of HU and gradually increased in amount thereafter. The virus DNA molecules synthesized during the initial 20 min after removal of HU, constitute the replicative intermediates of HSV DNA. It was calculated that the synthesis of HSV DNA proceeds at the rate of about 5 X 10(6) daltons per min.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200715     DOI: 10.1099/0022-1317-37-2-429

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis.

Authors:  Lucy Heinemann; Guy R Simpson; Nicola E Annels; Richard Vile; Alan Melcher; Robin Prestwich; Kevin J Harrington; Hardev S Pandha
Journal:  Mol Ther       Date:  2010-09-14       Impact factor: 11.454

2.  Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.

Authors:  L M Fox; J A Mekras; C B Bagwell; S B Greer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.

Authors:  B I Lidin; E W Lamon
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.